![Philippe Dubrou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Philippe Dubrou
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Graftys SA
![]() Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France.
10
| Holding Company | Medical Specialties | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Philippe Dubrou
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Biologics 4 Life SAS
![]() Biologics 4 Life SAS Pharmaceuticals: MajorHealth Technology Part of Graftys SA, Biologics 4 Life SAS develops injectable biomaterials to treat and prevent fractures caused by osteoporosis. The company is based in Jouques, France. The French company was founded in 2018 by Aurelien Valet, Alain Valet, Sébastien Genesta. Biologics 4 Life was acquired by Graftys SA on November 08, 2021. | Pharmaceuticals: Major | Founder Founder | |
THERAVET SA | Miscellaneous Commercial Services | Founder Director/Board Member | |
Apaxen SA
![]() Apaxen SA BiotechnologyHealth Technology Apaxen SA is a privately-held biotechnology company that was founded in 2018 and is based in an undisclosed location. The Belgian company has raised €5.4 million in equity and grant funding since its A round in 2019. Apaxen is focused on developing a pipeline of NLRP3 inflammasome inhibitors with a novel mechanism of action for the treatment of chronic inflammatory and autoimmune diseases. The company's clinical candidate, MFC-1040, is an orally bioavailable and selective small molecule NLRP3 inflammasome inhibitor that has demonstrated efficacy in multiple animal models of chronic inflammatory disease and pulmonary fibrosis. The company's team combines the experience required for clinical development of its products and is supported by a world-class team of scientific advisors. Apaxen has a pipeline of products at discovery and preclinical stages of development for the treatment of diseases associated with chronic inflammation that depend on NLRP3 inflammasome activation. The company was founded in 2018 by Gael Jalce, Enrico Jose Adolfo Bastianelli, and Bart Wuurman has been the CEO of the company since 2020. | Biotechnology | Founder Director/Board Member | |
BioMAdvanced Diagnostics SAS
![]() BioMAdvanced Diagnostics SAS Medical SpecialtiesHealth Technology BioMAdvanced Diagnostics SAS produces molecular diagnostic and biomarker tests related to the immune system. The company is based in Nantes, France. The French company was founded by Nicolas Bouler, Frédéric Pette, Sophie Brouard, Jean-Michel Bouler. Frédéric Pette has been the CEO since incorporation. | Medical Specialties | Founder | |
Pepric NV
![]() Pepric NV Miscellaneous Commercial ServicesCommercial Services Pepric NV develops imaging technology. It offers sensitive imaging systems with a long observation window for in-vivo molecular and functional imaging addressing pharmaceutical applications in drug development, pre-clinical testing, diagnostic imaging and translational medicine in general. The company was founded Stephanie Laura Gerard Claire Teughels in 2009 and is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Glob-Co SRL | Director/Board Member | ||
Pensionnat Henri Jaspar | Director/Board Member | ||
Innovation Fund (BE)
![]() Innovation Fund (BE) Investment ManagersFinance Innovation Fund is a venture capital firm founded in 2015. The firm headquartered located in Schaerbeek, Belgium. | Investment Managers | Private Equity Investor | |
DoseVue NV
![]() DoseVue NV Medical SpecialtiesHealth Technology DoseVue NV is developing innovative technologies for convenient and accurate in-vivo dosimetry. It offers DoseWire Series 100 & DoseWire Series 200. The company was founded by Emiliano D Agostino in March 2013 and is headquartered in Turnhout, Belgium. | Medical Specialties | Director/Board Member | |
Home EOS NV
![]() Home EOS NV Engineering & ConstructionIndustrial Services Home EOS NV is a company based in Farciennes, Belgium. Home EOS specializes in providing a serene and healthy living environment with effective and ecological acoustic insulation. The Belgian company was founded in 2014 and Pierre P. de Kettenis de Hollaeken has been the CEO of the company since 2016. | Engineering & Construction | Director/Board Member | |
The Louvain School of Management | College/University | Undergraduate Degree | |
Escuela Superior de Administración y Dirección de Empresas | College/University | Undergraduate Degree | |
Orthopaedic & Spine Development SAS
![]() Orthopaedic & Spine Development SAS Medical SpecialtiesHealth Technology Part of Implanet SA, Orthopaedic & Spine Development SAS is a French company that manufactures implants for spine surgery. The company is based in Avignon, France. The company was founded in 2005 by Nicolas Papillon. Nicolas Papillon has been the CEO since 2005. Orthopaedic & Spine Development was acquired by Implanet SA on May 18, 2021 for $3.65 million. | Medical Specialties | Chief Executive Officer | |
IMPLANET SA | Medical Specialties | Director/Board Member | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ProSkelia BV | Founder | ||
Hôpital Erasme
![]() Hôpital Erasme Hospital/Nursing ManagementHealth Services Part of Université Libre de Bruxelles, Hôpital Erasme is a medical facility located in Brussels, Belgium. The hospital offers polyclinics in Nivelles and Brussels, as well as specialized centers in psychiatry, geriatrics, and traumatology. | Hospital/Nursing Management | Corporate Officer/Principal | |
Tornier, Inc.
![]() Tornier, Inc. Hospital/Nursing ManagementHealth Services Tornier, Inc. provides healthcare services and distributes medical devices. It offers joint replacement products including hips, knees, shoulders, ankles, and other extremity prostheses. The company is headquartered in Bloomington, MN. | Hospital/Nursing Management | Chairman | |
Credendo Group SA
![]() Credendo Group SA Insurance Brokers/ServicesFinance Credendo Group SA operates as a credit insurance company. It offers trade credit insurance, financing, bonding, investment, financial guarantees, and risk participation solutions. The company was founded in 1921 and is headquartered in Brussels, Belgium. | Insurance Brokers/Services | Director/Board Member | |
TheClubDeal Capital Advisors SA (Private Equity)
![]() TheClubDeal Capital Advisors SA (Private Equity) Investment ManagersFinance TheClubDeal Capital Advisors SA (Private Equity) is a private equity/venture capital division of TheClubDeal Capital Advisors SA founded in 2016 by Nicolas de Moreau and Jean-Marc Legrand. The firm headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor | |
Gimv (Private Equity)
![]() Gimv (Private Equity) Investment ManagersFinance Gimv (Private Equity) is a Private Equity firm, a subsidiary of Gimv NV (XB: GIMB) founded in 1980. Gimv (Private Equity) is headquartered in Antwerp, Belgium. | Investment Managers | Private Equity Investor | |
Université de Namur ASBL | College/University | Undergraduate Degree | |
Katholieke Universiteit Leuven Law School | College/University | Graduate Degree | |
Tornier SAS
![]() Tornier SAS Medical SpecialtiesHealth Technology Tornier SAS engages in the orthopedic industry. The company was founded on April 27, 1970 and is headquartered in Montbonnot-Saint-Martin, France. | Medical Specialties | Chairman | |
Tornier Holding SAS
![]() Tornier Holding SAS Medical SpecialtiesHealth Technology Tornier Holding SAS operates as a holding company with interests in manufacturing orthopedic implants. The company was founded in November 1987 and is headquartered in Saint Ismier, France. | Medical Specialties | Director/Board Member | |
Vlerick Leuven Gent Management School | College/University | Masters Business Admin | |
University of Grenoble | College/University | Graduate Degree | |
Oreo Finance SASU
![]() Oreo Finance SASU Financial ConglomeratesFinance Oreo Finance SASU is a financial services provider. The private company was founded in 2007 and is based in Beaurains, France. | Financial Conglomerates | Chairman | |
ACG Management SAS
![]() ACG Management SAS Investment ManagersFinance ACG Management SAS (ACG) is the private equity subsidiary of Vivéris Holding SAS in France. The firm was formerly known as Vivéris Management SAS, established in 2000, and became ACG Management in 2014. Based in Marseille, with additional offices in Ajaccio and St. Denis de la Réunion and subsidiaries in New Caledonia and Tunisia, ACG is a multi-regional firm which provides technology venture capital, development capital, capital transmission and LBO services as well as a range of investment vehicles, including FCPIs, FIPs and FCPRs for institutional investors. | Investment Managers | Private Equity Investor | |
France Biotech Association
![]() France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member | |
Procter & Gamble Pharmaceuticals, Inc.
![]() Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Procter & Gamble Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its products include Actonel, Asacol, Enablex, Didronel, Macrobid, Macrodantin, Entex, and Ziac. The firm manufactures and markets a variety of over-the-counter and oral care products such as Crest, Oral-B, Prilosec OTC, Vicks, Metamucil, Pepto-Bismol, ThermaCare, and other related products. The company was founded in 1970 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SKEMA Business School | College/University | Undergraduate Degree |
Statistik
International
Belgien | 19 |
Frankreich | 11 |
Vereinigte Staaten | 4 |
Niederlande | 3 |
Argentinien | 2 |
Sektoral
Health Technology | 12 |
Consumer Services | 8 |
Finance | 7 |
Commercial Services | 5 |
Health Services | 3 |
Operativ
Director/Board Member | 21 |
Founder | 12 |
Corporate Officer/Principal | 9 |
Chairman | 5 |
Private Equity Investor | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Philippe Dubrou
- Unternehmensverbindungen